With a pharma industry as a historical driver of the local economy, life sciences activities account today for 3.4% of Catalan GDP and is composed of some of the strongest and most innovative companies and research institutions. Top global Pharma companies have installed their productive centres in Catalonia, creating Europe’s densest pharma ecosystem.
Specifically, the fine chemicals sub-sector concentrates 75% of Spanish production here, making Catalonia home to the world’s sub-sector leaders. Furthermore, Spain ranks second in Europe in the number of clinical trials and 78% of all trials involve at least one centre in Catalonia.
Major pharma players congregate in Catalonia
Catalonia is home to the five biggest Spanish pharmaceutical companies: Almirall, Esteve, Ferrer, Grífols and Uriach. Furthermore, R&D spending of the Catalan pharmaceutical industry accounts for 32.1% of total Catalan industry spending in R&D. Catalonia is also home to Lacer, Kern Pharma and Isdin, and to the main API companies in the country. Furthermore, many international companies are established here, such as Novartis, Sanofi, Boehringer-Ingelheim, Bayer, Roche, Menarini, Pierre Fabre, Pfizer, and Intas Pharmaceuticals-Accord.
A logistics network supporting the industry
Catalonia has a strong logistics ecosystem specialised in pharmaceutics, healthcare and APIs, in line with all current legislation. Major multinational companies such as Sanofi, Synthon, BBraun, Moehs and Grífols operate internationally from Catalonia, and other companies have established logistics centres to operate on a national or Southern European level, such as Roche Diagnostics and Disalfarm (a logistic centre for Bayer, Boehringer Ingelheim and Novartis). The region also counts on first-class infrastructures with specialised pharmaceutic facilities.